Return
High-precision multiclass cell classification by supervised machine learning on lectin microarray data
DOI:10.1016/j.reth.2020.09.005.png)
Abstract
En 中文
Introduction: Establishment of a cell classification platform for evaluation and selection of human pluripotent stem cells (hPSCs) is of great importance to assure the efficacy and safety of cell-based therapy. In our previous work, we introduced a discriminant function that evaluates pluripotency from the cells' glycome. However, it is not yet suitable for general use. Methods: The current study aims to establish a high-precision cell classification platform introducing supervised machine learning and test the platform on glycome analysis as a proof-of-concept study. We employed linear classification and neural network to the lectin microarray data from 1577 human cells and categorized them into five classes including hPSCs. Results: The linear-classification-based model and the neural-network-based model successfully predicted the sample type with accuracies of 89% and 97%, respectively. Conclusions: Because of the high recognition accuracies and the small amount of computing resources required for these analyses, our platform can be a high precision conventional cell classification system for hPSCs. (C) 2020, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
Keywords:
Lectin microarray
Linear classification
Neural network
Artificial intelligence
Pluripotent stem cells
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.5
Papers:
1.1K
Citations:
2.0K
Organization
Cited Papers
Lectin microarrays identify cell-specific and functionally significant cell surface glycan markers
GLYCOBIOLOGY
IF3.3
HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin
NATURE CHEMICAL BIOLOGY
IF13.7
Concise Review: Human Embryonic Stem Cells-What Have We Done? What Are We Doing? Where Are We Going?
Stem Cells
IF3.6

